*Corresponding author:
Emilia Angela Lo Schiavo Arisawa, Biostimulation and Tissue Repair Laboratory, University of Paraíba Valley, 2911 Shishima Hifumi Avenue, São José dos Campos, São Paulo, BrazilReceived: October 25, 2017; Published: October 30, 2017
DOI: 10.26717/BJSTR.2017.01.000475
To view the Full Article Peer-reviewed Article PDF
Spinal cord injury (SCI) is one of the most common and devastating injuries found in the neurological clinic [1,2]. It is defined as damage to the spinal cord that causes temporary or permanent changes in its function, resulting in significant neurological dysfunction and disability [3,4]. SCI has physical, social and occupational consequences for patients and their families, resulting in loss of independence and an increase in the mortality rate [3]. In addition, studies show that expenses for care of patients with SCI can reach US$1.1-4.6 million per patient throughout life. Thus, it is extremely important to develop effective treatments [5].
Abbreviations: SCI: Spinal Cord Injury; AM: Amniotic Membrane; AECs: Amniotic Epithelial Cells; AMSC: Amniotic Mesenchymal Stromal Cells
International Association of Landscape Archaeology, Czech Glass Society, Czech Republic
Department of Chemistry, Semenov Institute of Chemical Physics, USSR Academy of Sciences, Moscow, Russia
Pharmaco-kinetics, dynamics and Drug Metabolism, Touro College of Pharmacy, USA
Professor of Nuclear Medicine, Faculty of Medicine and Surgery, University of Milan, Milan, Italy
Associate Professor at Department of Breast and Thyorid Surgey, Chongqing General Hospital, China